NCT05134272

Brief Summary

This study will compare the motor outcomes for five infants with asymmetrical hand function (AHF) who will receive two, three week episodes of standard care separated by a three week episode of mCIMT paired with Neuromuscular Electrical Stimulation. The results of this study will inform decisions on the feasibility and efficacy of the treatment for use in a larger study for infants with AHF at risk for unilateral cerebral palsy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 8, 2021

Completed
9 days until next milestone

Study Start

First participant enrolled

November 17, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 24, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 16, 2022

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2023

Completed
Last Updated

June 27, 2023

Status Verified

June 1, 2023

Enrollment Period

12 months

First QC Date

November 8, 2021

Last Update Submit

June 26, 2023

Conditions

Keywords

infantconstraint induced movement therapyearly interventioncerebral palsy

Outcome Measures

Primary Outcomes (1)

  • Change in hand use based on the Hand Assessment of Infants

    A criterion, norm referenced assessment that evaluates and measures goal directed both hand use and possible upper limb asymmetry in infants at risk of developing cerebral palsy,aged 3-12 months.

    Baseline, week 4, week 7, week 10

Secondary Outcomes (2)

  • Change in motor skills based on the Peabody Developmental Motor Scales-2

    Baseline, week 4, week 7, week 10, 18 months CCA

  • Assisting Hand Assessment Version 4.4

    18 months CCA

Study Arms (1)

mCIMT plus NMES

Phase 1: Infants will receive therapy 1 hour/day, 1 day/week for 3 weeks while wearing a sock 1 hour/day. Parents will complete home program activities 1 hour/day, 6 days/week for 3 weeks. Phase 2:Infants will receive therapy 2 hours/day, 3 days/week for 3 weeks while wearing a splint 24 hours/day. Parents will complete home program activities 1 hour/day, 6 days/week for 3 weeks. Phase 3:Infants will receive therapy 1 hour/day, 1 day/week for 3 weeks while wearing a sock 1 hour/day. Parents will complete home program activities 1 hour/day, 6 days/week for 3 weeks.

Device: Neuromuscular electrical stimulationBehavioral: Modified constraint induced movement therapyBehavioral: Standard care for infant with asymmetrical hand function

Interventions

Neuromuscular Electrical Stimulation will be applied by the therapist to infant's finger flexors and extensor for 15 min./day, 3x/week.

Also known as: NMES
mCIMT plus NMES

Modified CIMT will consist of constraint 24 hours/day using a splint in addition to therapy two hours/day, 3x/week for three weeks. Parents will be trained to carry over home program activities one hour/day, 6 days/week.

Also known as: mCIMT
mCIMT plus NMES

Infants will receive one hour of therapy, one time/week for three weeks. Parents will be trained to carry over home program activities one hour/day, 6 days/week. In addition the infant will wear a sock on their preferred hand during the hour of therapy/home program activity.

mCIMT plus NMES

Eligibility Criteria

Age7 Months - 10 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Infants with asymmetrical hand function

You may qualify if:

  • Infant is 7-10 months of age (CCA)
  • Clinical presentation of asymmetrical hand function,
  • Grade 2/5 movement in more impaired upper extremity,
  • Demonstrate potential to participate in 6 hours of therapy/week during 3 week episode of mCIMT-NMES, as determined by principal investigator,
  • Parent/guardian willing to be partners in study and participate in follow-up assessments until child is 18 months of age

You may not qualify if:

  • Medical or sensory condition that prevents full therapy participation (active seizures, significant visual impairment)
  • Received Botox injection to more impaired upper extremity within last 6 months,
  • NMES contraindicated (impaired skin integrity, presence of pacemaker, clotting disorder),
  • Previous UE surgery or nerve injury (brachial plexus)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Minnesota

Maple Grove, Minnesota, 55369, United States

Location

MeSH Terms

Conditions

HemiplegiaCerebral Palsy

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

ParalysisNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsBrain Damage, ChronicBrain DiseasesCentral Nervous System Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Kathy S Grinde, PT

    Children's Minnesota

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Physical Therapist, Rehab Clinical Specialist

Study Record Dates

First Submitted

November 8, 2021

First Posted

November 24, 2021

Study Start

November 17, 2021

Primary Completion

November 16, 2022

Study Completion

May 31, 2023

Last Updated

June 27, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Locations